Isuzinaxib hydrochloride

N/A

Report date: 2023/04/03 15:36:05
NME

Base Information

Drug NameIsuzinaxib hydrochloride
Drug Alias NameAPX-115EWHA-18278
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase inhibitors
TargetsNADPH oxidase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Diabetes Mellitus, Type 2Acute Kidney Injury +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEwha Woman'S University
China Registration ClassN/A

Develop Information

Active CompaniesAptabio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Acute Kidney InjuryDiabetic Nephropathies
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A